Reuters logo
BRIEF-Immunocellular Therapeutics Q3 loss per share $0.40
November 21, 2017 / 9:17 PM / 21 days ago

BRIEF-Immunocellular Therapeutics Q3 loss per share $0.40

Nov 21 (Reuters) - Immunocellular Therapeutics Ltd

* Immunocellular Therapeutics announces third quarter 2017 financial results

* Q3 loss per share $0.40 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below